DPP4 and type 2 diabetes mellitus: To test our hypothesis, we used db/db mice, since db/db mice is recognized as one of the most popular animal models of type 2 diabetes with obesity [17, 18], and also used linagliptin for specific DPP-4 inhibition, because linagliptin is shown to exert brain protective effect in mice independently of blood glucose control [10].